Figure 2.

Targeting of the ventral striatal and ventral capsular area has been has been shown to be safe in patients with obsessive compulsive disorder as well as treatment refractory depression. In open label studies, it was shown that it is possible to modulate networks related to mood and affect. This figure illustrates deep brain stimulation targeting along the anterior limb of the internal capsule into the ventral striatal area, as intended in the ongoing clinical trial.